-- 
SWISS DAYBOOK: Synthes, Nestle, Sonova, Santhera

-- B y   K l a u s   W i l l e
-- 
2011-10-19T05:41:10Z

-- http://www.bloomberg.com/news/2011-10-19/swiss-daybook-synthes-nestle-sonova-santhera.html
Synthes Inc. (SYST) , the medical-device
maker that’s agreed to be acquired by Johnson & Johnson, posted
an 11 percent increase in third-quarter sales on growth in
Europe and  Asia . Third-quarter revenue climbed to $1 billion
from $907.2 million a year earlier, the company said. Sales
topped $1 billion for the first time.  EQUITIES:
* Sonova Holding AG (SOON) ’s first-half sales were 763 million Swiss
francs ($852 million).
*Santhera Pharmaceuticals says it will present data on Catena
for the treatment of Duchenne muscular dystrophy.
*Nestle plans to increase its number of brands, CEO Paul Bulcke
said in interview  ECONOMICS/POLITICS:
*Swiss government holds regular meeting at 9:00 a.m.  MARKETS:
*The benchmark SMI declined 0.7 percent to 5,682.51
*The SPI fell 0.6 percent to 5,148.34
*The Stoxx Europe 600 Index lost 0.4 percent to 235.33
*The MSCI Asia-Pacific Index gained 0.8 percent at 7:30 a.m.
Swiss time
*Euro-franc traded at 1.2376 at 7:31 a.m.  To contact the reporter on this story:
Klaus Wille in Zurich at 
 kwille@bloomberg.net   To contact the editor responsible for this story:
Craig Stirling at 
 cstirling1@bloomberg.net  